Inhibition of the respiratory burst in mouse macrophages by ultra-low doses of an opioid peptide is consistent with a possible adaptation mechanism

FEBS Lett. 1994 Nov 28;355(2):114-6. doi: 10.1016/0014-5793(94)01109-5.

Abstract

The respiratory burst induced by phorbol myristate acetate in mouse macrophages was inhibited by ultra-low doses (10(-15)-10(-13) M) of an opioid peptide [D-Ala2]methionine enkephalinamide. The effect disappeared at concentrations above and below this range. The inhibition approached 50% and was statistically significant (P < 0.001). Increasing the time of the opioid incubation with cells brought about a shift in the maximal effect to lower concentrations of the opioid (from 10(-13) to 5 x 10(-15) M) and led to a decrease in the value of the effect, fully in accord with the previously proposed adaptation mechanism of the action of ultra-low doses.

MeSH terms

  • Adaptation, Physiological
  • Animals
  • Dose-Response Relationship, Drug
  • Enkephalin, Methionine / administration & dosage
  • Enkephalin, Methionine / analogs & derivatives*
  • Enkephalin, Methionine / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Macrophages, Peritoneal / drug effects*
  • Macrophages, Peritoneal / metabolism*
  • Male
  • Mice
  • Mice, Inbred CBA
  • Respiratory Burst / drug effects*
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Enkephalin, Methionine
  • enkephalinamide-Met, Ala(2)-
  • Tetradecanoylphorbol Acetate